2013年9月5日讯 /生物谷BIOON/ --中国台湾地区决定加强发展医疗器械研发力度，政府将采取税务减免和政府奖励等激励措施来鼓励企业进入医疗器械行业，增强研发实力。据当地媒体报道，政府正在准备一项法律草案以帮助精密器械生产者发展其产品。现如今，亚洲和其他新兴市场已经成为了国际医疗器械巨头必争之地，如Medtronic、Boston Scientific、Covidien等医疗器械领域的领头羊都已经迫不及待的开始瓜分这些市场份额。而台湾地区2011年医疗器械的销售总额达到了34亿美元，这一数字在2012年又增加了7%。

详细英文报道：

Taiwanese legislators say they're on the cusp of passing tax cuts and government subsidies to support medical device company R&D and training, something likely to help kickstart further industry growth there.

The Taipei Times reports the legislature will prepare a draft bill on the matter in its upcoming session with an eye toward aiding makers of high-risk medical devices in particular who are focused on local development and manufacturing. Legislative Speaker Wang Jin-pyng told the news organization his peers agree such a bill should be passed and that they're focusing right now on hashing out the details.

Asia and other emerging markets remain the next big frontier for medical device multinationals, including Medtronic ($MDT), Boston Scientific ($BSX), Covidien ($COV), General Electric ($GE) and many others. How big? Taiwan medical device and equipment sales nearly hit the $3.42 billion mark in 2011 and jumped 7% higher in 2012. That level of growth is robust, to be sure, and Taiwan's leaders are doing everything they can to keep the positive trajectory going and maybe even accelerate it.

Outside of China and India, Taiwan offers enormous opportunities for companies seeking new markets, but also a sophisticated healthcare market in which to develop and make their products. Similarly, Taiwan wants to grow its own medical device manufacturing, and tax credits and subsidies will spur development of companies and technologies that can compete with the big guys in emerging markets and beyond.

The Taiwanese government launched an initiative in 2012 to nurture industry growth in kidney dialysis machinery, respiratory care equipment, in vitro diagnostic technology, microsurgery and high-end dental device tech. Tax cuts and subsidies to spur development of new products will help keep the growth engine running, and they may even accelerate how much it expands down the line.